JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,159 | 355,802 | 89,612 | Feb 15, 2018, 07:31 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,157 | 355,631 | 89,614 | Feb 14, 2018, 07:24 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 07, 2018 | Option Exercise | $85.49 | 2,700 | 230,823 | 93,771 | Feb 09, 2018, 07:27 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 08, 2018 | Option Exercise | $53.81 | 6,994 | 376,313 | 97,268 | Feb 09, 2018, 07:27 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 01, 2018 | Option Exercise | $68.77 | 8,334 | 573,129 | 100,638 | Feb 02, 2018, 07:26 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 22, 2018 | Sale | $69.00 | 205,078 | 14,151,407 | 173,371 | Jan 24, 2018, 06:46 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 17, 2018 | Sale | $44.88 | 58,262 | 2,614,678 | 99,963 | Jan 19, 2018, 09:00 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Dec 18, 2017 | Sale | $44.96 | 1,816 | 81,647 | 70,832 | Dec 20, 2017, 04:37 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 08, 2017 | Option Exercise | $55.98 | 684 | 38,290 | 72,648 | Nov 09, 2017, 07:32 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 02, 2017 | Sale | $40.12 | 13,332 | 534,880 | 79,998 | Nov 03, 2017, 07:30 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Sep 13, 2017 | Sale | $44.95 | 12,850 | 577,608 | 37,439 | Sep 14, 2017, 07:31 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Aug 29, 2017 | Sale | $39.95 | 12,869 | 514,117 | 50,289 | Aug 31, 2017, 07:44 PM |
JUNO | | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 10, 2016 | Sale | $24.14 | 12,921 | 311,848 | 35,719 | Nov 10, 2016, 08:56 PM |